Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
08/2003
08/21/2003US20030158407 A Fluorescent dyes for labelling biopolymers and cell surface, a conjugated with polynucleotides or nucleotides
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158177 Treating or preventing obesity
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/19/2003US6608194 Hypolipidemic, antihyperglycemic, antiobesity and hypocholes-terolemic agents
08/19/2003US6608019 Alkoxy-substituted perfluorocompounds
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003US20030153763 Indolinyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro isoquinolinyl, benz(cd)indolinyl and 5,6-dihydrophen anthridinyl compounds; treating neurodegenerative disorders
08/14/2003US20030153760 Treating 1-(3,5- bis(trifluoromethyl)phenyl)ethan-1-one with bis((pentamethylcyclopentadienyl)rhodium chloride) and (S,R)-cis-1-amino-2-hydroxy-indane in the presence of isopropanol
08/14/2003US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003CN1436178A Process for synthesis of (2R,2-alpha-R,3a)-2-ÒÇö1-(3,5-bis (trifluoromethyl) phenyl) ethoxyÒÇò-3-(4-fluophenyl)-1,4-oxazine
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/07/2003WO2003018565A8 Method for synthesizing oxazinones
08/07/2003US20030149032 For use applications in which reversible color changes or darkening is induced by sunlight; efficiency
08/07/2003US20030149031 For therapy of inflammation
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP1331922A1 Photo-labile pro-fragrance conjugates
08/05/2003US6602869 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
07/2003
07/31/2003WO2003062213A1 Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/31/2003US20030144277 Piperizinones as modulators of chemokine receptor activity
07/29/2003US6600040 Reacting 2-alpha-R)-4-benzyl-2-(1-(3,5-bis(trifluoromethyl)phenyl)ethox y-1, 4-oxazin-3-one with a 4-fluorophenyl organometallic reagent in first solvent followed by hydrogentation solvent
07/29/2003US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents
07/29/2003US6599899 Benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment
07/29/2003US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor
07/29/2003US6599861 Herbicides
07/24/2003WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/23/2003EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides
07/17/2003WO2003057679A1 Photochromic oxazine compounds and methods for their manufacture
07/17/2003WO2003057254A1 Preventives/remedies for urinary disturbance
07/17/2003CA2471760A1 Preventives/remedies for urinary disturbance
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/15/2003US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/10/2003WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130382 Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing same
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/09/2003EP1325927A2 Synthesis of oligonucleotides
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1165496B1 Substituted aniline compounds
07/09/2003EP1156798B1 Felbamate derived compounds
07/09/2003EP0966490B1 Catalyst compositions for the polymerization of olefins
07/09/2003CN1429200A Anthranyl amides and their use as medicaments
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/09/2003CN1113603C Azine derivatives
07/03/2003WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists
07/03/2003US20030125553 Process for the preparation of new antidiabetic agents
07/03/2003US20030125552 Heating an isocyanate derivative with a symmetric quinone in presence of triphenylarsen oxide catalyst to form 2,2-diphenyl-phenanthro (9,10)-2H-(1,4)-oxazine derivatives
07/03/2003US20030125551 Benzoxazines, thermosetting resins comprised thereof, and methods for use thereof
07/03/2003US20030125494 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/02/2003EP1322625A2 Reagents for labeling biomolecules having aldehyde or ketone moieties
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003CN1427818A Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
06/2003
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/25/2003EP1321460A2 Surfactant composition and method of making the same
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1425656A 1-(alpha-aminobenzyl)-2 naphthol ketal (acetal) compound and its preparation and use
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583155 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases
06/24/2003US6583144 Piperazine substituted isoquinoline, 1,3-benzoxazine, or 1,3-benzothiazine derivatives; inhibitors against the biosynthesis of triglycerides and secretion of apolipoprotein b and treatment of hyperlipidemia
06/24/2003CA2126337C 2-amino-1,3-propanediol compound and immunosuppressant
06/19/2003WO2003050154A2 Catalytic carbonylation of three and four membered heterocycles
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/12/2003WO2003048138A1 [1.2]-oxazin-3,5-diones
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/11/2003EP1317511A1 Oxazine derivatives
06/11/2003EP1317490A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
06/11/2003EP1317456A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/10/2003US6576730 For the polymerization of unsaturated vinyl and/or vinylidene monomers
06/05/2003WO2003045956A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates
06/05/2003WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003CA2465840A1 Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates
06/05/2003CA2463592A1 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/04/2003EP1315741A2 A method for treating allergies
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 112